:
Skip to main content
HHS.gov
Menu
Main navigation
CDS Home
Overview
CDS Connect
CDS Innovation Collaborative
CEDAR
Evaluation
Funding Opportunities
Resources
Contact Us
CDS Connect Global
Welcome
About
Governance
Repository
Authoring Tool
Community
FAQ
Repository User Guide
An official website of the Department of Health & Human Services
Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
Patient-Centered Outcomes Research
Clinical Decision Support
Accelerating Evidence into Practice through CDS
Search
Enter the terms you wish to search for.
Authoring Tool
CDS Connect Login
Main navigation
CDS Home
Overview
CDS Connect
CDS Innovation Collaborative
CEDAR
Evaluation
Funding Opportunities
Resources
Contact Us
CDS Connect Global
Welcome
About
Governance
Repository
Authoring Tool
Community
FAQ
Repository User Guide
Welcome
org
Elimu Informatics, Inc.
Elimu Informatics, Inc.
Artifacts Published
Jul 30 2021
Preferred therapy recommendation for adult asthmatic Step 1-to-2 transition
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Asthma
Anti-Asthmatic Agents
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for adult asthmatic Step 4 to 5 transition
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Asthma
Anti-Asthmatic Agents
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for adult Step 2 asthmatic before advancing
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Asthma
Anti-Asthmatic Agents
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for adult Step 4 asthmatic before advancing
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Asthma
Anti-Asthmatic Agents
Budesonide, Formoterol Fumarate Drug Combination
Mometasone Furoate, Formoterol Fumarate Drug Combination
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for asthmatic Step 2-to-3 transition
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Child
Asthma
Anti-Asthmatic Agents
Budesonide, Formoterol Fumarate Drug Combination
Mometasone Furoate, Formoterol Fumarate Drug Combination
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for asthmatic Step 3-to-4 transition
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Child
Asthma
Anti-Asthmatic Agents
Budesonide, Formoterol Fumarate Drug Combination
Mometasone Furoate, Formoterol Fumarate Drug Combination
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for child Step 4 asthmatic before advancing
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Child
Asthma
Anti-Asthmatic Agents
Budesonide, Formoterol Fumarate Drug Combination
Mometasone Furoate, Formoterol Fumarate Drug Combination
Created:
2021-07-30
Jul 30 2021
Preferred therapy recommendation for Step 3 asthmatic before advancing
Artifact Type
Event-Condition-Action (ECA) rule
Publisher
Elimu Informatics, Inc.
Adult
Young Adult
Child
Asthma
Anti-Asthmatic Agents
Budesonide, Formoterol Fumarate Drug Combination
Mometasone Furoate, Formoterol Fumarate Drug Combination
Created:
2021-07-30